Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

694
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
694
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

582
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
582
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.8K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.8K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.2K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.2K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.8K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

4-anilinoquinoline triazines: a novel class of hybrid antimalarial agents.

European journal of medicinal chemistry·2011
Same author

Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice.

The Journal of cell biology·2010
Same author

Buffalo hepcidin: characterization of cDNA and study of antimicrobial property.

Veterinary research communications·2010
Same author

High viral load and deregulation of the progesterone receptor signaling pathway: association with hepatitis E-related poor pregnancy outcome.

Journal of hepatology·2010
Same author

Gα13 and Rho mediate endosomal trafficking of CXCR4 into Rab11+ vesicles upon stromal cell-derived factor-1 stimulation.

Journal of immunology (Baltimore, Md. : 1950)·2010
Same author

Dlk1 is necessary for proper skeletal muscle development and regeneration.

PloS one·2010

Related Experiment Video

Updated: Mar 2, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.2K

Phenothiazine: A Better Scaffold against Tuberculosis.

Satheeshkumar Sellamuthu1, Mohammad Faizan Bhat1, Ashok Kumar1

  • 1Pharmaceutical Chemistry Research Laboratory, Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi-221005, India.

Mini Reviews in Medicinal Chemistry
|May 11, 2017
PubMed
Summary

Phenothiazine molecules show promise against drug-resistant Tuberculosis (TB). They are effective against susceptible and resistant Mycobacterium tuberculosis strains and can enhance first-line drug efficacy.

Keywords:
PhenothiazineSARpsychotropicrepurposingresistancetuberculosis.

More Related Videos

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.4K
Author Spotlight: Advancing Therapeutics to Treat Vibriosis in Humans and Aquatic Organisms
03:29

Author Spotlight: Advancing Therapeutics to Treat Vibriosis in Humans and Aquatic Organisms

Published on: May 31, 2024

996

Related Experiment Videos

Last Updated: Mar 2, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.2K
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.4K
Author Spotlight: Advancing Therapeutics to Treat Vibriosis in Humans and Aquatic Organisms
03:29

Author Spotlight: Advancing Therapeutics to Treat Vibriosis in Humans and Aquatic Organisms

Published on: May 31, 2024

996

Area of Science:

  • Medicinal Chemistry
  • Microbiology
  • Pharmacology

Background:

  • Tuberculosis (TB) incidence is rising in developing nations, driven by multidrug-resistant and extensively drug-resistant strains.
  • There is an urgent need for novel anti-TB drugs with different mechanisms of action to combat resistant Mycobacterium tuberculosis.
  • Phenothiazine derivatives have emerged as a promising chemical scaffold for anti-tubercular drug discovery.

Purpose of the Study:

  • To review the anti-tubercular activity of phenothiazine-based molecules reported in the last decade.
  • To highlight the potential of phenothiazines against both drug-susceptible and drug-resistant TB.
  • To assess the role of phenothiazines as supplementary treatment to enhance existing TB therapies.

Main Methods:

  • Literature search for studies published within the last 10 years focusing on phenothiazine derivatives and their anti-tubercular activity.
  • Analysis of reported efficacy against susceptible and resistant strains of Mycobacterium tuberculosis.
  • Evaluation of studies investigating the combination of phenothiazines with first-line anti-TB drugs.

Main Results:

  • Phenothiazine-containing molecules demonstrate significant activity against both susceptible and resistant strains of Mycobacterium tuberculosis.
  • Several phenothiazine derivatives have shown promising anti-tubercular effects, warranting further investigation.
  • Supplementary administration of phenothiazines has been shown to enhance the efficacy of conventional first-line anti-TB drugs.

Conclusions:

  • Phenothiazine derivatives represent a valuable class of compounds for developing new anti-tuberculosis agents.
  • These molecules offer potential solutions for overcoming drug resistance in Tuberculosis treatment.
  • Further research into phenothiazine-based therapies could lead to improved treatment strategies for Tuberculosis.